Share
Journal Information
Issue
Vol. 13. Issue 4.Pages 312-470 (July - August 2014)
Hepatology highlights
Hepatology highlights
Rohit Pai, Vladimir Marquez-Azalgara, Eric M. Yoshida
Ann Hepatol. 2014;13:312-5
Open access
Concise review
Predicting outcome in primary biliary cirrhosis
Willem J. Lammers, Kris V. Kowdley, Henk R. van Buuren
Ann Hepatol. 2014;13:316-26
Open access
What is changing in indications and treatment of hepatic hemangiomas. A review
Adriana Toro, Ahmed-Emad Mahfouz, Annalisa Ardiri, Michele Malaguarnera, Giulia Malaguarnera, Francesco Loria, Gaetano Bertino, Isidoro Di Carlo
Ann Hepatol. 2014;13:327-39
Open access
Original article
Long term changes in liver histology following treatment of chronic hepatitis C virus
Mitchell L. Shiffman, Richard K. Sterling, Melissa Contos, Sarah Hubbard, April Long, Velimir A. Luketic, R. Todd Stravitz, Michael Fuchs, Arun J. Sanyal
Ann Hepatol. 2014;13:340-9
Open access
Peginterferon alpha-2b plus ribavirin for chronic hepatitis C virus mixed genotype infection
Ching-Chung Lin, Chia-Hsien Wu, Huan-Lin Chen, I-Tsung Lin, Shen-Yung Wang, Tsang-En Wang, Horng-Yuan Wang, Shou-Chuan Shih, Ming-Jong Bair
Ann Hepatol. 2014;13:350-5
Open access
PNPLA3 rs738409 causes steatosis according to viral & IL28B genotypes in hepatitis C
Javier Ampuero, José A. Del Campo, Lourdes Rojas, José R. García-Lozano, Ricard Solá, Raúl Andrade, José A. Pons, José M. Navarro, ... Manuel Romero-Gómez
Ann Hepatol. 2014;13:356-63
Open access
A phase 2 study of filibuvir in combination with pegylated IFN alfa and ribavirin for chronic HCV
Maribel Rodriguez-Torres, Eric M. Yoshida, Patrick Marcellin, Subasree Srinivasan, Vivek S. Purohit, Cunshan Wang, Jennifer L. Hammond
Ann Hepatol. 2014;13:364-75
Open access
Long term nucleotide and nucleoside analogs treatment in chronic hepatitis B HBeAg negative genotype D patients and risk for hepatocellular carcinoma
Adriano M. Pellicelli, Pascal Vignally, Vincenzo Messina, Antonio Izzi, Ettore Mazzoni, Angelo Barlattani, Donato Bacca, Mario Romano, ... Giorgio Barbarini
Ann Hepatol. 2014;13:376-85
Open access
Epidemiology of HCC in Brazil: Incidence and risk factors in a ten-year cohort
Denise C. Paranaguá-Vezozzo, Suzane K. Ono, Mónica V. Alvarado-Mora, Alberto Q. Farias, Marione Cunha-Silva, João I.D. França, Venancio A.F. Alves, Morris Sherman, Flair José Carrilho
Ann Hepatol. 2014;13:386-93
Open access
Preoperative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma: a single center analysis
Lei Jianyong, Zhong Jinjing, Wang Wentao, Yan Lunan, Zhou Qiao, Li Bo, Wen Tianfu, Xu Minqing, ... Wei Yongang
Ann Hepatol. 2014;13:394-402
Open access
Plasma cytokine levels imbalance in cirrhotic patients with impaired glucose tolerance and diabetes mellitus. A prospective study
Diego García-Compeán, Joel O. Jáquez-Quintana, Fernando J. Lavalle-González, José A. González-González, Héctor J. Maldonado-Garza, Jesús Z. Villarreal-Pérez
Ann Hepatol. 2014;13:403-10
Open access
Right atrial pressure may impact early survival of patients undergoing transjugular intrahepatic portosystemic shunt creation
Ahmad Parvinian, James T. Bui, M. Grace Knuttinen, Jeet Minocha, Ron C. Gaba
Ann Hepatol. 2014;13:411-9
Open access
Hemodynamic effect of Carvedilol vs. propranolol in cirrhotic patients: Systematic review and meta-analysis
Nancy Aguilar-Olivos, Miguel Motola-Kuba, Roberto Candia, Marco Arrese, Nahúm Méndez-Sánchez, Misael Uribe, Norberto C Chávez-Tapia
Ann Hepatol. 2014;13:420-8
Open access
Adult human liver contains intermediate-type proteasomes with different enzymatic properties
Sabrina Gohlke, Alexander Kloβ, Michael Tsokos, Kathrin Textoris-Taube, Christin Keller, Peter-Michael Kloetzel, Burkhardt Dahlmann
Ann Hepatol. 2014;13:429-38
Open access
Deep sequencing analysis of microRNA expression in porcine serum-induced hepatic fibrosis rats
Shanfei Ge, Xiaowei Wang, Jianping Xie, Xin Yi, Fei Liu
Ann Hepatol. 2014;13:439-49
Open access
Images in hepatology
Hepatocellular adenoma: Different entities for a single lesion
Pierre Bedossa
Ann Hepatol. 2014;13:450-1
Open access
Case report
Rhabdomyolysis in a hepatitis C virus infected patient treated with telaprevir and simvastatin
Clara T.M.M. de Kanter, Matthijs van Luin, Caroline Solas, David M. Burger, Jan Maarten Vrolijk
Ann Hepatol. 2014;13:452-5
Open access
Persistent hepatic encephalopathy secondary to portosystemic shunt occluded with Amplatzer device
Ariadna Ramírez-Polo, Ernesto Márquez-Guillén, Adrián J. González-Aguirre, Iván E. Casanova-Sánchez, Rafael Chávez-Ruiz, Eduardo Carrillo-Maravilla, Eric López-Méndez
Ann Hepatol. 2014;13:456-60
Open access
Hepatitis B reactivation in patients with multiple myeloma and isolated positive hepatitis B core antibody: a call for greater cognizance
Ju Dong Yang, Mohit Girotra, Alejandro Restrepo, Sarah Waheed, Bart Barlogie, Andres Duarte-Rojo
Ann Hepatol. 2014;13:461-5
Open access
Letter to the editor
Severe aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome in a patient with non-A-E hepatitis virus infection
Hamid Shaaban, Dron Gauchan, Anmol Kahlon, Michael Maroules
Ann Hepatol. 2014;13:466-7
Open access
Liver news elsewhere
Hepatopulmonary syndrome: Is it time to redefine the MELD exception score for better organ allocation and outcomes?
Mateo Porres-Aguilar, Juan Fernando Gallegos-Orozco
Ann Hepatol. 2014;13:468-70
Open access
Publish in
Annals of Hepatology
Special content about COVID-19
- Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study
- Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cells
- P-2 NASH IS IMPROVED THROUGH MODIFICATIONS IN H3K9 METHYLATION BY PIRFENIDONE ACTING AS JMJD2B DEMETHYLASE ANTAGONIST.
- O-2 EVALUATION OF RISK FACTORS AND PROGNOSIS OF HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION
Affiliated societies
